[Federal Register Volume 65, Number 137 (Monday, July 17, 2000)]
[Notices]
[Pages 44059-44060]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-17982]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-00-43]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

[[Page 44060]]

Proposed Project

    Nursing Homes' Access to Influenza Vaccine and Use of Rapid 
Influenza Tests and Antivirals--New--National Center for Infectious 
Diseases (NCID)--Uncontrolled nursing home influenza outbreaks can 
result in illness in  60 percent and death in  10 
percent of residents. Vaccine is the primary means to prevent influenza 
and its complications. However, outbreaks can occur despite high 
vaccination levels. The use of rapid diagnostic tests and the timely 
administration of antiviral medications can lessen the impact of 
influenza outbreaks. In 1998, a study was conducted among nursing homes 
in 9 states to determine the use of vaccine, rapid influenza tests, and 
antivirals, amantadine and rimantadine. Since that time, new rapid 
diagnostic tests and neuraminidase inhibitor antiviral medications have 
been approved. In addition, a substantial delay in the distribution of 
influenza vaccine and a possible vaccine shortage are anticipated for 
the 2000-01 influenza season.
    The purpose of this study is to assess nursing homes' access to 
vaccine in 2000-01, the use of rapid influenza diagnostic tests, and 
the influenza inhibitor antivirals. A survey will be mailed to a sample 
of randomly selected nursing homes in the same 9 states surveyed in 
1998. The results will be used to evaluate resident and staff 
vaccination levels and the use of rapid influenza tests and antiviral 
medications. We will also assess the relationship between access to 
vaccine and the occurrence of outbreaks. There is no cost to the 
respondents.

----------------------------------------------------------------------------------------------------------------
                                                                  Number of       Avg. burden/
                 Respondents                     Number of      responses per   respondents (in    Total burden
                                                respondents       respondent          hrs)
----------------------------------------------------------------------------------------------------------------
Nursing Home staff..........................            1017                1            10/60              170
----------------------------------------------------------------------------------------------------------------


    Dated: July 11, 2000.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 00-17982 Filed 7-14-00; 8:45 am]
BILLING CODE 4163-18-P